France· FR:63068769
CEPROTIN 1000 UI/10 ml, poudre et solvant pour solution injectable
A medicinal product containing protéine c humaine, registered in France by TAKEDA MANUFACTURING AUSTRIA (AUTRICHE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PROTÉINE C HUMAINE
- Manufacturer
- TAKEDA MANUFACTURING AUSTRIA (AUTRICHE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009563391671 flacon(s) en verre - 1 flacon(s) en verre de 10 ml avec aiguille(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Protéine c humaine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCeprotin 1000 IUTakeda Manufacturing Austria
- SwitzerlandCeprotin 1000 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaCEPROTINTakeda Manufacturing Austria AG, Vídeň
- FinlandCeprotinBaxter AG
- United KingdomCeprotin 1000unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandCeprotinBaxter Vaccine AG
- IcelandCeprotinBaxter AG*
- PolandCeprotinTakeda Manufacturing Austria AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ceprotin
- Liechtenstein · Ceprotin
- Norway · Ceprotin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a9f4a59-27e2-4ad9-8785-c99e5fd44759 GET /v1/drugs/9a9f4a59-27e2-4ad9-8785-c99e5fd44759?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63068769",
"date_amm": "2001-07-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/01/190",
"substance": "PROTÉINE C HUMAINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about protéine c humaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.